Integral Diagnostics Limited (ASX:IDX)
2.180
+0.010 (0.46%)
Jun 1, 2026, 4:10 PM AEST
Integral Diagnostics Stock Forecast
Stock Price Forecast
The 12 analysts that cover Integral Diagnostics stock have a consensus rating of "Buy" and an average price target of $3.11, which forecasts a 42.66% increase in the stock price over the next year. The lowest target is $2.04 and the highest is $3.80.
Price Target: $3.11 (+42.66%)
Analyst Consensus: Buy
* Price targets were last updated on Mar 24, 2026.
Analyst Ratings
The average analyst rating for Integral Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 9 | 8 | 8 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 13 | 13 | 13 | 13 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ord Minnett | Ord Minnett | Buy Maintains $3.30 → $3.20 | Buy | Maintains | $3.30 → $3.20 | +46.79% | Mar 24, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $2.57 | Buy | Maintains | $2.57 | +17.89% | Mar 4, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $3.80 | Buy | Maintains | $3.80 | +74.31% | Feb 26, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $3.50 → $3.20 | Buy | Maintains | $3.50 → $3.20 | +46.79% | Feb 25, 2026 |
| Jarden | Jarden | Buy Maintains $3.35 → $3.25 | Buy | Maintains | $3.35 → $3.25 | +49.08% | Feb 25, 2026 |
Sources: Price targets and consensus ratings provided by TipRanks. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.